![Grannum R. Sant](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Grannum R. Sant
Direktor/Vorstandsmitglied bei Cellanyx Diagnostics LLC
Profil
Grannum R.
Sant is currently a Director at Cellanyx Diagnostics LLC and Xennials Therapeutics, Inc. He previously served as an Independent Director at Photocure ASA. He was also a Vice President & Head of Medical Affairs at Sanofi, Inc. from 2003 to 2013 and a VP & Head-Global Medical Affairs Rare at Genzyme Corp.
from 2010 to 2013.
He has also worked as a Professor at Tufts University School of Medicine.
Dr. Sant holds a doctorate degree from University College Dublin.
Aktive Positionen von Grannum R. Sant
Unternehmen | Position | Beginn |
---|---|---|
Cellanyx Diagnostics LLC
![]() Cellanyx Diagnostics LLC Medical SpecialtiesHealth Technology Cellanyx Diagnostics LLC is a company that is developing a cancer testing platform to aid clinical decision-making. The company is based in Beverly, MA and was founded by Ashok Chander and Michael Manak. The company's technology provides quantitative assessments of individual cancer cells in biopsy samples using multiple biochemical and biophysical markers of tumor aggressiveness and metastatic potential. The company has demonstrated clinical proof-of-concept with their lead test in development, which aims to improve risk stratification in men with prostate cancer. | Direktor/Vorstandsmitglied | - |
Xennials Therapeutics, Inc.
![]() Xennials Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xennials Therapeutics, Inc. develops and manufactures transformative therapies. | Direktor/Vorstandsmitglied | - |
Ehemalige bekannte Positionen von Grannum R. Sant
Unternehmen | Position | Ende |
---|---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Corporate Officer/Principal | 01.01.2013 |
Sanofi, Inc.
![]() Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Corporate Officer/Principal | 01.01.2013 |
Tufts University School of Medicine | Corporate Officer/Principal | - |
PHOTOCURE ASA | Direktor/Vorstandsmitglied | - |
Ausbildung von Grannum R. Sant
University College Dublin | Doctorate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 1 |
---|---|
PHOTOCURE ASA | Health Technology |
Private Unternehmen | 4 |
---|---|
Genzyme Corp.
![]() Genzyme Corp. Medical SpecialtiesHealth Technology Genzyme Corp. engages in development and manufacture of specialty therapeutic, surgical and diagnostic product. It serves in the areas of rare genetic diseases, multiple sclerosis, cardiovascular diseases and endocrinology. The company was founded on June 8, 1981 and is headquartered in Cambridge, MA. | Health Technology |
Sanofi, Inc.
![]() Sanofi, Inc. Drugstore ChainsRetail Trade Part of Abbott Laboratories, Sanofi, Inc. is a company based in New York, NY. | Retail Trade |
Cellanyx Diagnostics LLC
![]() Cellanyx Diagnostics LLC Medical SpecialtiesHealth Technology Cellanyx Diagnostics LLC is a company that is developing a cancer testing platform to aid clinical decision-making. The company is based in Beverly, MA and was founded by Ashok Chander and Michael Manak. The company's technology provides quantitative assessments of individual cancer cells in biopsy samples using multiple biochemical and biophysical markers of tumor aggressiveness and metastatic potential. The company has demonstrated clinical proof-of-concept with their lead test in development, which aims to improve risk stratification in men with prostate cancer. | Health Technology |
Xennials Therapeutics, Inc.
![]() Xennials Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Xennials Therapeutics, Inc. develops and manufactures transformative therapies. | Health Technology |